Security key
00650F109
Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT)
CUSIP: 00650F109
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 159,541,000
- Total 13F shares
- 133,849,942
- Share change
- +1,030,171
- Total reported value
- $1,179,397,231
- Put/Call ratio
- 8.6%
- Price per share
- $8.83
- Number of holders
- 223
- Value change
- +$14,000,370
- Number of buys
- 110
- Number of sells
- 83
Report period
Q1 2023
Institutions
223
Top holders
10
ADPT full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Adaptive Biotechnologies Corp SEC filings
Adaptive Biotechnologies Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00650F109
Recent filing periods:
Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
19%
|
29,993,708
|
$229,151,929 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.8%
|
12,374,197
|
$94,538,865 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.4%
|
11,794,168
|
$90,107,444 | — | 31 Dec 2022 | |
| Matrix Capital Management Company, LP |
13F
|
Company |
7.3%
|
11,572,590
|
$88,414,588 | — | 31 Dec 2022 | |
| ARK Investment Management LLC |
13F
|
Company |
5.8%
|
9,201,245
|
$70,297,512 | — | 31 Dec 2022 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
3.4%
|
5,352,315
|
$40,891,687 | — | 31 Dec 2022 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
3.4%
|
5,352,315
|
$40,731,117 | — | 31 Dec 2022 | |
| Blue Water Life Science Advisors, LP |
13F
|
Company |
1.9%
|
3,030,434
|
$23,152,516 | — | 31 Dec 2022 | |
| Bellevue Group AG |
13F
|
Company |
1.9%
|
2,960,131
|
$22,615,401 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
2,501,453
|
$19,111,101 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
2,145,643
|
$16,392,000 | — | 31 Dec 2022 | |
| Aristotle Atlantic Partners, LLC |
13F
|
Company |
1.2%
|
1,880,567
|
$14,367,532 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
1,838,466
|
$14,045,000 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.88%
|
1,407,690
|
$10,754,751 | — | 31 Dec 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.88%
|
1,407,186
|
$10,750,901 | — | 31 Dec 2022 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.85%
|
1,354,433
|
$10,347,868 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.81%
|
1,290,575
|
$9,859,993 | — | 31 Dec 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.79%
|
1,256,911
|
$9,602,800 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
0.68%
|
1,080,221
|
$8,252,888 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.66%
|
1,048,869
|
$8,013,000 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.64%
|
1,019,739
|
$7,790,000 | — | 31 Dec 2022 | |
| Pier Capital, LLC |
13F
|
Company |
0.63%
|
1,012,401
|
$7,734,744 | — | 31 Dec 2022 | |
| Senator Investment Group LP |
13F
|
Company |
0.63%
|
1,000,000
|
$7,640,000 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.62%
|
995,409
|
$7,604,924 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.52%
|
824,399
|
$6,298,408 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.51%
|
806,793
|
$6,164,000 | — | 31 Dec 2022 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.42%
|
668,202
|
$5,106,000 | — | 31 Dec 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.4%
|
632,728
|
$4,834,000 | — | 31 Dec 2022 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.4%
|
630,869
|
$4,819,839 | — | 31 Dec 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.39%
|
622,718
|
$4,757,565 | — | 31 Dec 2022 | |
| Eagle Health Investments LP |
13F
|
Company |
0.38%
|
607,860
|
$4,644,050 | — | 31 Dec 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.38%
|
598,564
|
$4,573,029 | — | 31 Dec 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.37%
|
592,687
|
$4,528,129 | — | 31 Dec 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.36%
|
578,398
|
$4,418,961 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.34%
|
543,278
|
$4,150,644 | — | 31 Dec 2022 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.3%
|
473,785
|
$3,619,717 | — | 31 Dec 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.26%
|
422,281
|
$3,226,227 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.26%
|
415,800
|
$3,177,000 | — | 31 Dec 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
407,634
|
$3,114,324 | — | 31 Dec 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.25%
|
403,395
|
$3,083,000 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
391,563
|
$2,991,538 | — | 31 Dec 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.23%
|
370,471
|
$2,830,397 | — | 31 Dec 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.23%
|
368,900
|
$2,818,000 | — | 31 Dec 2022 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.23%
|
366,230
|
$2,797,997 | — | 31 Dec 2022 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.18%
|
292,743
|
$2,236,000 | — | 31 Dec 2022 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.18%
|
292,357
|
$2,234,000 | — | 31 Dec 2022 | |
| BERYLSON CAPITAL PARTNERS, LLC |
13F
|
Company |
0.18%
|
289,726
|
$2,213,507 | — | 31 Dec 2022 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.17%
|
267,631
|
$2,045,000 | — | 31 Dec 2022 | |
| Swiss National Bank |
13F
|
Company |
0.15%
|
241,500
|
$1,845,060 | — | 31 Dec 2022 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.13%
|
209,836
|
$1,603,147 | — | 31 Dec 2022 |
Institutional Holders of Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT) as of Q1 2023
As of 31 Mar 2023,
Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT) was held by
223 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,849,942 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BlackRock Inc., Matrix Capital Management Company, LP, ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., Blue Water Life Science Advisors, LP, STATE STREET CORP, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/.
This page lists
223
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
216
Q1 2023 holders
223
Holder diff
7
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.